We believe deep science based ideas don’t fit in traditional VC framework of evaluation and need a different structure to succeed:

• These ideas most often originate inside academic or corporate labs and are funded by grant or R&D expenses. That support takes the ideas to a proof of science with very limited ability to invest in commercial validation. Hence the commercial viability of the ideas may or may not have been tested for investment worthiness.
• The team of researchers who worked on the ideas would have great research credentials but may not have a co-founder who has strong business building credentials, making a VC think about completeness of the team.
• The ambition of the researcher may be more aligned to furthering the search in related or unrelated fields and they may not be willing to drop their research career altogether to pursue one idea.

Through our combined knowledge and resource pool, the platform will create a conducive environment for insights to translate into ideas which we can grow into successful businesses together.

Over the last six years, we have run one of the most successful accelerator programs in the country and evaluated 1,000+ ideas every year. The scale and outcome approach of our program has given us a vantage point to identify gaps and big problem areas. Being in the thick of mentoring and fundraising with our startups, we have built a strong network to match the skill and expertise needed by a startup at the right time. We will sharply identify problem areas that are worth solving and unlock go-to-market channels through which businesses can then scale up.

We are passionate about supporting home-grown IP-based startups. Our founders have collectively supported research with 500 Cr worth of grant till date and Axilor has funded 7 out of top 10 IP based HealthTech startups in India. We want to take it a step further and support research by providing a path to make meaningful impact from research outcomes.

India spends ~1.5% of its gross domestic product on healthcare. It is neither feasible nor adequate to increase this spend. Innovation is the only way to improve health outcomes.

Further, this sector requires a very deep understanding of the problem and the context. This implies a great need to facilitate collaboration.

And, most importantly, innovations in health will have the most impact. About a fifth of all deaths worldwide occur in India. The Non-Communicable Diseases like Cardiovascular diseases, Cancer, Chronic Respiratory Diseases, Diabetes, etc. are estimated to account for around 60% of all deaths.